Intrinsic value of Basel Medical Group Ltd Ordinary Shares (BMGL)
Live fair value data for Basel Medical Group Ltd Ordinary Shares (BMGL) is currently unavailable. Please check again shortly.
Current Price: $60.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Basel Medical Group Ltd Ordinary Shares (BMGL) undervalued or overvalued?
Based on the current model output, Basel Medical Group Ltd Ordinary Shares appears to be undervalued with a upside of 53.00%.
Fair value vs market price — Basel Medical Group Ltd Ordinary Shares (BMGL)
Unlock premium access to view the live fair value comparison against current market price for BMGL.
Frequently Asked Questions - BMGL
How is BMGL intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for BMGL.
Is BMGL undervalued or overvalued right now?
BMGL is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for BMGL: open their intrinsic value pages.